❀

iEmoji Feeds @Pdr (pdrpuff1)

1.

pdrpuff1
Pdr @pdrpuff1
$Ocugen has a new Drug Development Program Manager.
15 Aug 22 copy & paste +upvote -downvote $Ocugen has a new Drug Development Program Manager. πŸ‘ https://t.co/zwbPhM1pjX

2.

pdrpuff1
Pdr @pdrpuff1
Someone recently asked why I still believe:
They quietly positioned themselves to catapult back to new highs.
Mul… twitter.com/i/web/status/1…
09 Aug 22 copy & paste +upvote -downvote Someone recently asked why I still believe: πŸ‘‰They quietly positioned themselves to catapult back to new highs. πŸ‘‰Mul… https://t.co/gKXpM1GLYE
3.
pdrpuff1
Pdr @pdrpuff1
Study published in Nature reports, COVAXIN (BBV152) generated a persistent cell mediated memory immune response fo… twitter.com/i/web/status/1…
Retweet of status by @Ocugen
20 Jul 22 copy & paste +upvote -downvote Study published in Nature reports, COVAXINβ„’ (BBV152) generated a persistent cell mediated memory immune response fo… https://t.co/MN5HQEVOaO
4.
pdrpuff1
Pdr @pdrpuff1
6 months with no posts, now this.
10 Jul 22 copy & paste +upvote -downvote 6 months with no posts, now this. πŸ€” https://t.co/XNSTYF3NaN
5.
pdrpuff1
Pdr @pdrpuff1
β€œβ€¦actively preparing for commercialization in Mexico.”
06 May 22 copy & paste +upvote -downvote β€œβ€¦actively preparing for commercialization in Mexico.” πŸ‡²πŸ‡½ https://t.co/zHWJdHVzrm

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* πŸ™ˆπŸ™ˆπŸ™Š

2.

ReganBrittany
ReganBrittany @ReganBrittany
Nanana diva is the female version of the hustlaaaa! #gettinmoney
14 Jan 13 copy & paste +upvote -downvote Nanana diva is the female version of the hustlaaaa! #gettinmoney πŸ’°πŸ’΅πŸ’Έ
3.
Rickygonz1215
Rickygonz1215 @Rickygonz1215
If I weighed 182 I'd be cut
13 Jan 13 copy & paste +upvote -downvote If I weighed 182 I'd be cut πŸ‘ŒπŸ’ͺπŸ’ͺπŸ’ͺ
https://www.iemoji.com/feed/pdrpuff1
Back to top